Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T48945 | Target Info | |||
Target Name | TERT messenger RNA (TERT mRNA) | ||||
Synonyms |
Telomerase-associated protein 2 (mRNA); Telomerase catalytic subunit (mRNA); TRT (mRNA); TP2 (mRNA); TCS1 (mRNA); HEST2 (mRNA); EST2 (mRNA)
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | TERT | ||||
Biochemical Class | mRNA target | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Human immunodeficiency virus Protease (HIV PR) | Successful Target | ||||
UniProt ID | POL_HV1B1 | |||||
Gene Name | HIV PR | |||||
Synonyms |
HIV Retropepsin; HIV PR
Click to Show/Hide
|
|||||
Representative Drug(s) | Doxorubicin | Drug Info | IC50 = 900 nM | [1] | ||
Co-Target Name | Aurora kinase A (AURKA) | Clinical trial Target | ||||
UniProt ID | AURKA_HUMAN | |||||
Gene Name | AURKA | |||||
Synonyms |
hARK1; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; STK6; STK15; IAK1; Breast tumor-amplified kinase; BTAK; Aurora/IPL1-related kinase 1; Aurora-related kinase 1; Aurora-A; Aurora 2; AYK1; AURA; ARK1; ARK-1; AIRK1; AIK
Click to Show/Hide
|
|||||
Representative Drug(s) | Doxorubicin | Drug Info | IC50 = 40 nM | [2] | ||
Co-Target Name | Hypoxia-inducible factor 2 alpha (HIF-2A) | Successful Target | ||||
UniProt ID | EPAS1_HUMAN | |||||
Gene Name | EPAS1 | |||||
Synonyms |
bHLHe73; PASD2; PAS domain-containing protein 2; Member of PAS protein 2; MOP2; Hypoxia-inducible factor 2-alpha; HLF; HIF2A; HIF2-alpha; HIF-2-alpha; HIF-1-alpha-like factor; Endothelial PAS domain-containing protein 1; EPAS-1; Class E basic helix-loop-helix protein 73; Basic-helix-loop-helix-PAS protein MOP2
Click to Show/Hide
|
|||||
Representative Drug(s) | Doxorubicin | Drug Info | EC50 = 120 nM | [3] | ||
Co-Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | ||||
UniProt ID | HIF1A_HUMAN | |||||
Gene Name | HIF1A | |||||
Synonyms |
bHLHe78; Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; Member of PAS protein 1; MOP1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1 A; Hypoxia inducible factor 1; HIF1-alpha; HIF1 alpha; HIF-1alpha; HIF-1-alpha; HIF-1 alpha; Class E basic helix-loop-helix protein 78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Doxorubicin | Drug Info | EC50 = 120 nM | [3] | ||
Co-Target Name | DNA topoisomerase II alpha (TOP2A) | Clinical trial Target | ||||
UniProt ID | TOP2A_HUMAN | |||||
Gene Name | TOP2A | |||||
Synonyms |
DNA topoisomerase II, alpha isozyme; DNA topoisomerase 2alpha; DNA topoisomerase 2-alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Doxorubicin | Drug Info | IC50 = 600 nM | [4] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Developing a dynamic pharmacophore model for HIV-1 integrase. J Med Chem. 2000 Jun 1;43(11):2100-14. | ||||
REF 2 | Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors. Eur J Med Chem. 2011 Sep;46(9):3690-5. | ||||
REF 3 | Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii. J Nat Prod. 2009 May 22;72(5):805-12. | ||||
REF 4 | Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria. J Med Chem. 2019 Mar 28;62(6):2950-2973. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.